WAM
DNA.WS

Wolverine Asset Management’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Wolverine Asset Management’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-46,690
Closed -$1.32K – 1859
2024
Q2 		$1.32K Sell
46,690
-200
-0.4% -$11 ﹤0.01% 1523
2024
Q1 		$4.22K Hold
46,890
– – ﹤0.01% 1404
2023
Q4 		$4.94K Buy
46,890
+24,173
+106% +$3.56K ﹤0.01% 1472
2023
Q3 		$5.11K Sell
22,717
-1,212
-5% -$326 ﹤0.01% 1558
2023
Q2 		$6.27K Sell
23,929
-131
-0.5% -$26 ﹤0.01% 1451
2023
Q1 		$4.33K Sell
24,060
-913
-4% -$209 ﹤0.01% 1564
2022
Q4 		$4.99K Buy
+24,973
New +$10.7K ﹤0.01% 1746

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Wolverine Asset Management's DNA.WS Position: Q3 2024 in Review

Wolverine Asset Management sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 46,690 shares — an estimated $1.32K sold.

Wolverine Asset Management first reported a position in DNA.WS in Q4 2022 and held it in 7 quarters. The position peaked at $6.27K in Q2 2023. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • Wolverine Asset Management reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 46,690 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $1.32K.
  • Wolverine Asset Management first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q4 2022 and held it in 7 quarters.
  • Wolverine Asset Management's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $6.27K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on Wolverine Asset Management's 13F filing for Q3 2024, filed 4 Nov 2024.